Sort
82,697 grants matching “vaccine development”
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals
$393,953,893Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
COVID-19: NIAID Clinical Research Support Services (CRSS)
$385,065,810Bambra Strokes · Ppd Development Lp · N01 · FY2021 · AI
National Biomedical Information Services
$366,260,951Michael Huerta · National Library Of Medicine · ZIH · FY2024 · LM
National Biomedical Information Services
$358,847,685Michael Huerta · National Library Of Medicine · ZIH · FY2023 · LM
National Biomedical Information Services
$347,681,166Jerry Sheehan · National Library Of Medicine · ZIH · FY2022 · LM
National Biomedical Information Services
$332,242,445Patricia Brennan · National Library Of Medicine · ZIH · FY2021 · LM
PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORONAVIRUS VACCINES
$277,585,346Kiran Datta · Leidos Biomedical Research, Inc. · N01 · FY2023 · AI
National Biomedical Information Services
$250,355,446Betsy Humphreys · National Library Of Medicine · ZIH · FY2009 · LM
National Center/Emerging Infectous Diseases &Biodefense
$128,021,180Boston University Medical Campus · UC6 · FY2003 · AI
XSEDE: eXtreme Science and Engineering Discovery Environment
$125,628,752John W Towns · University Of Illinois At Urbana-Champaign · · FY2011 · CSE
National Biocontainment Laboratory (NBL)
$110,090,673University Of Texas Medical Br Galveston · UC6 · FY2003 · AI
Frederick National Laboratory for Cancer Research (FNLCR) Center for SARS-CoV-2 Serological Sciences
$85,668,587Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
COVID-19: NIAID Clinical Research Support Services (CRSS)
$72,422,544Bambra Strokes · Ppd Development Lp · N01 · FY2020 · AI
HIV Prevention Trials Network Leadership and Operations Center
$70,307,771Myron S Cohen · Family Health International · UM1 · FY2021 · AI
Establishment and operation of a Vaccine Pilot Plant
$66,352,968Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2024 · AI
Establishment and operation of a Vaccine Pilot Plant
$66,062,291Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI
Metropolitan AntiViral Drug Accelerator
$65,141,731David S Perlin · Hackensack University Medical Center · U19 · FY2022 · AI
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
$61,429,109Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Integrated Research Facility at Fort Detrick
$58,051,257Connie Schmaljohn · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Frederick National Laboratory for Cancer Research (FNLCR) Center for SARS-CoV-2 Serological Sciences
$57,909,079Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA
UTMB-Novartis Alliance for Pandemic Preparedness
$56,163,625Vineet D Menachery · University Of Texas Med Br Galveston · U19 · FY2022 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$55,953,346Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
LOC: HIV Vaccine Trials Network
$55,377,361Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2018 · AI
HIV Vaccine Research and Development
$52,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI
LOC: HIV Vaccine Trials Network
$50,375,222Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · AI